KRAS and neoplasm: Notably, when mice treated with both sotorasib and anti-PD-1 to clear KRAS G12C tumors were rechallenged with KRAS G12D tumor cells, an immune memory response halted the growth of the tumor, highlighting the adaptive immune reactions to shared antigens [48].